HEPIONE THERAPEUTICS INC

New York, NY · Biotech · Private

Antibody and vaccine platform targeting small molecules and peptides, with initial focus on a fentanyl vaccine for overdose prevention

Grants
$523K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A Fentanyl Vaccine to Prevent Overdose$261,742
Federal grantDepartment of Health and Human Services · Phase I · A Fentanyl Vaccine to Prevent Overdose$261,742
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1340RES GROUP, INC.——
1341DUOPHOS, LLC——
1342Bioprinting Laboratories Inc.——
1343HEPIONE THERAPEUTICS INC——
1344ARMIDA LABS, INC.——
1345Lung Biotechnology PBC——
1346SXRNA TECHNOLOGIES, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Anti-fentanyl Antibodiesapplication
  • Methods For Generating High Affinity Antibodies Against Fentanylapplication
  • Anti-fentanyl Antibodiesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.